OCTAVE EVENTS

Octave at the ACTRIMS Forum 2026 Annual Meeting

February 5 - 7, 2026
San Diego, California

We'd love to meet you at ACTRIMS!

Are you interested in learning more about the Octave MSDA Test?
Are you an existing user wanting to review specific cases with our MSL team?
Are you curious to discuss future partnership opportunities?

Our pod hours

Thursday, February 5: 7:30 AM – 7:30 PM
Friday, February 6: 7:30 AM – 7:30 PM

Schedule time with

Octave

The science behind our innovation

Engage with our researchers and collaborators at Poster Session 1 (February 5, 5:45PM)

P019: Characterizing MSDA Score and Biomarker Associations with Disease Activity, Progression, and PIRA in a Pilot MS Study of Four Well-Defined Patient Groups at AUMC

P021: Real-world Utilization of a Novel Multi-Analyte Blood-Based Biomarker Panel, the Octave® Multiple Sclerosis Disease Activity (MSDA) Test in Clinical Practice Across the United States

P037: Using the Octave® MSDA Test to Identify Differences in Disease Activity and Panel Biomarkers Between Natalizumab and Anti-CD20 Therapies

P040: Multi-protein Biomarker Test Results for Participants Treated with Ublituximab from the Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab (ENHANCE)

Octave @ ACTRIMS

Our team is excited to meet with you at ACTRIMS!

Ferhan Qureshi

Senior Vice President, Biomarker R&D

Olena Stadnyuk

Vice President, Business Dev.

Terrie Livingston

Vice President, Medical Affairs

Jonathan Verrier

Medical Director, Multiple Sclerosis

Marissa Clark

Principal Medical Science Liaison

Andrea Osking

Associate Medical Director, Field

Jennifer Chester

Medical Science Liaison